At a time when some Americans are concerned about the safety of a COVID-19 vaccine, tens of thousands have already volunteered to help bring one into existence.
As of last week, more than 107,000 people had signed up to take part in testing.
“That’s why we’re optimistic that we’re going to be able to get the trials enrolled in an expeditious way. I think we can do what we need to do,” said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
The milestone was reached just a week after the National Institutes of Health launched a clinical trial network for vaccines and other prevention tools to fight the pandemic.
More are still needed but the initial surge will go a long way toward filling the requirement for at least 30,000 volunteers each for the four companies that plan to launch Phase 3 clinical trials of